540
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain

Pages 823-831 | Received 16 Feb 2016, Accepted 16 May 2016, Published online: 07 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Concetta Dagostino, Massimo Allegri, Valerio Napolioni, Simona D’Agnelli, Elena Bignami, Antonio Mutti & Ron HN van Schaik. (2018) CYP2D6 genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort. Pharmacogenomics and Personalized Medicine 11, pages 179-191.
Read now

Articles from other publishers (3)

Morgan R. Price, Zachary A. Cupler, Cheryl Hawk, Edward M. Bednarz, Sheryl A. Walters & Clinton J. Daniels. (2022) Systematic review of guideline-recommended medications prescribed for treatment of low back pain. Chiropractic & Manual Therapies 30:1.
Crossref
Atsushi Kitamura, Kei Higuchi, Toshiki Kurosawa, Takashi Okura, Yoshiyuki Kubo & Yoshiharu Deguchi. (2022) Naltrexone Transport by a Proton-Coupled Organic Cation Antiporter in hCMEC/D3 Cells, an <i>in Vitro</i> Human Blood–Brain Barrier Model. Biological and Pharmaceutical Bulletin 45:10, pages 1585-1589.
Crossref
Zhu Luo, Jia Miao, Shiqing Shu, Ying Wang, Xiaohong Zhu, Chao Hu & Yali Shen. (2019) Pharmacokinetics and Bioequivalence Evaluation of a New Oxycodone Tamper-Resistant Tablet Administered with an Opioid Antagonist in Patients with Chronic Pain. Clinical Drug Investigation 40:2, pages 139-148.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.